August is celebrated in the Philippines as ASEAN Month, marking the founding of the Association of Southeast Asian Nations (ASEAN) on Aug. 8, 1967. Nearly six decades later, ASEAN has grown into a dynamic regional community of nearly 700 million people and the world's fifth-largest economy. While its progress has long been measured by expanding trade, investment, and regional cooperation, one reality has become increasingly clear: ASEAN's future competitiveness will depend as much on the health of its people as on the strength of its economies.

This year's ASEAN Month carries particular significance as the Philippines assumes the ASEAN Chairmanship for 2026 under the theme "Navigating Our Future, Together." At a time when Southeast Asia confronts profound demographic, epidemiological, and technological change, the Chairmanship offers the Philippines a unique opportunity to help shape a regional agenda that places resilient, people-centered, and future-ready health systems at the core of ASEAN's continued development.

Health is no longer merely a social sector concern. It has become a strategic investment in human capital, economic resilience, and regional security. Healthy populations are more productive, more innovative, and better equipped to contribute to sustained economic growth. Conversely, weak health systems, widening health inequalities, and delayed access to quality healthcare undermine workforce productivity, drive up public expenditure, and threaten long-term development throughout the region.

ASEAN's healthcare systems stand at a pivotal moment. Rapid population ageing; the growing burden of noncommunicable diseases (NCDs) such as diabetes, cardiovascular disease, stroke, chronic respiratory disease, and cancer; persistent shortages of healthcare professionals; and unequal access to quality care are placing increasing pressure on health systems across Southeast Asia. NCDs already account for the majority of deaths in the region, and the World Health Organization has noted that health workforce density in several ASEAN member states remains below recommended thresholds for achieving universal health coverage. These challenges are compounded by high out-of-pocket healthcare expenditures in many member states, which continue to expose millions of families to financial hardship.

Yet this period of transformation also presents unprecedented opportunities. Advances in digital health, artificial intelligence (AI), telemedicine, electronic health records, and predictive analytics are reshaping healthcare delivery. When supported by sound governance, trusted data systems, and appropriate safeguards, these innovations can improve disease prevention, strengthen public health surveillance, expand access to care in underserved communities, and make health systems more efficient and responsive.

Against this backdrop, the Philippines has placed health high on ASEAN's agenda by advancing three mutually reinforcing priorities: promoting healthier populations through disease prevention; building stronger and more resilient health systems supported by a well-trained workforce and digital innovation; and deepening regional cooperation to ensure more equitable access to quality healthcare.

These priorities are closely aligned with ASEAN's long-term vision of building a resilient, innovative, and people-centered community, and they build on the foundation of the ASEAN Post-2015 Health Development Agenda, the current regional framework for health cooperation among member states. Healthy children learn better. Healthy adults remain productive longer. Healthy communities are more resilient during crises. Investing in health therefore strengthens not only individual well-being but also ASEAN's economic competitiveness and social stability.

The first priority recognizes that prevention remains the most effective investment any health system can make. The Philippines is championing regional strategies that address the growing burden of NCDs through health promotion, healthier lifestyles, early diagnosis, and community-based interventions. Encouraging better nutrition, regular physical activity, tobacco control, responsible alcohol consumption, and timely screening can significantly reduce the long-term burden of chronic diseases while improving quality of life.

Preparing ASEAN for an ageing population is equally important. Longer life expectancy is one of the region's greatest achievements, but it also demands health systems capable of providing comprehensive, person-centered care throughout the life course. Several Southeast Asian nations are undergoing demographic transitions at a faster pace than many advanced economies did, compressing the time available to adapt health and social systems. Expanding geriatric services, strengthening long-term care, supporting caregivers, and integrating health and social services will become increasingly important as Southeast Asia's older population continues to grow.

Strengthening the healthcare workforce must remain another regional priority. Expanding education, professional development, and ethical mobility opportunities for physicians, nurses, pharmacists, and allied health professionals will help ensure that all ASEAN member states have access to the skilled workforce needed to meet evolving healthcare demands. Likewise, continued investment in digital health infrastructure can bridge longstanding gaps in healthcare delivery, particularly in geographically isolated and underserved communities, while common principles for interoperability, cybersecurity, and ethical AI governance will help maximize the benefits of technological innovation.

Health equity must remain central to these efforts. Expanding access to maternal and child health services, mental healthcare, immunization, and other essential health services is fundamental to achieving universal health coverage across the region. Reducing disparities in access to healthcare not only improves health outcomes but also strengthens social cohesion and supports more inclusive economic growth.

The private sector likewise has an indispensable role to play. Governments alone cannot address the complex health challenges confronting Southeast Asia. Partnerships with organizations such as the US-ASEAN Business Council and the ASEAN Business Advisory Council (ASEAN-BAC) Philippines are helping advance science, technology, and innovation to strengthen regional health systems. These collaborations promote the responsible use of AI, improve data governance, encourage preventive models of care, and support regulatory readiness — demonstrating how public-private collaboration can accelerate meaningful and sustainable health reforms.

The COVID-19 pandemic fundamentally changed how governments view healthcare. It demonstrated that health security and economic security are inseparable. Countries with resilient health systems recovered more quickly, protected livelihoods more effectively, and restored economic activity sooner. It also underscored an important reality: infectious diseases do not respect national borders, making regional cooperation indispensable rather than optional. In response, ASEAN established the ASEAN Centre for Public Health Emergencies and Emerging Diseases (ACPHEED) to strengthen regional capacity for coordinated disease surveillance, risk assessment, and response.

As ASEAN looks ahead, strengthening preparedness for future health emergencies must remain a collective priority. Whether confronting emerging infectious diseases, antimicrobial resistance, or the growing health impacts of climate change, ASEAN's ability to respond collectively will determine not only the health of its people but also the resilience of its economies.

The Philippines is therefore advocating stronger regional disease surveillance, closer information sharing, and enhanced cross-border cooperation to enable the rapid detection of health threats and the timely mobilization of resources during emergencies. Building resilient supply chains for medicines, vaccines, diagnostics, and other essential health technologies is equally important to ensure that future disruptions do not compromise patient care when it is needed most.

Trust is another critical ingredient in effective regional health cooperation. It enables governments to share timely scientific information and public health data. Among regulatory authorities, it facilitates cooperation and reliance.

One area where regional cooperation can deliver tangible benefits is pharmaceutical regulation. Patients benefit when safe, effective, and quality-assured medicines become available more quickly. Achieving this objective requires regulatory systems that are science-based, transparent, efficient, and internationally aligned.

The pharmaceutical industry has long supported ASEAN's efforts toward regulatory convergence, regulatory reliance, and the harmonization of science-based standards. These initiatives seek to reduce unnecessary duplication, strengthen regulatory performance, and accelerate patient access to innovative medicines while maintaining rigorous standards of safety, quality, and efficacy.

Regulatory reliance has emerged as one of the most effective tools for strengthening regulatory systems across the region. By leveraging scientific assessments conducted by trusted reference authorities, regulatory agencies can make more efficient use of limited resources while reducing avoidable delays in patient access to new therapies.

Across Southeast Asia, health authorities and regulatory agencies — including Malaysia's National Pharmaceutical Regulatory Agency (NPRA), Singapore's Health Sciences Authority (HSA), and the Philippine Food and Drug Administration (FDA) — continue to deepen collaboration in pursuit of these shared objectives.

The Philippines' ASEAN Chairmanship also presents an opportunity to reinvigorate one of the region's most significant long-term initiatives: the ASEAN Harmonization of Pharmaceutical Registration. Through mechanisms such as the ASEAN Common Technical Dossier (ACTD) and the ASEAN Pharmaceutical Regulatory Framework (APRF), member states continue working toward aligning technical requirements and regulatory processes across the region. These initiatives help reduce technical barriers, improve regulatory efficiency, encourage pharmaceutical innovation, and ultimately allow patients to benefit more quickly from advances in medical science.

While regulatory harmonization is often viewed through the lens of trade facilitation, its greatest beneficiaries are patients. More efficient regulatory pathways mean faster access to life-saving medicines, vaccines, and other health technologies. For governments, harmonization strengthens regulatory performance and makes better use of scarce public resources. For healthcare systems, it contributes to greater resilience and responsiveness. For industry, it creates a more predictable and innovation-friendly environment that encourages investment, research, and regional partnerships.

Ultimately, ASEAN's greatest asset is neither its markets nor its natural resources — it is its people. Investing in their health is an investment in the region's productivity, resilience, and shared prosperity. By placing people at the center of regional cooperation, the Philippines has a unique opportunity during its ASEAN Chairmanship to help build a healthier, stronger, and more future-ready ASEAN.

Teodoro B. Padilla is the executive director of the Pharmaceutical and Healthcare Association of the Philippines, which represents the biopharmaceutical medicines and vaccines industry in the country. Its members are at the forefront of developing, investing, and delivering innovative medicines, vaccines, and diagnostics for Filipinos to live healthier and more productive lives.